Denna sida på svenska
Loading profile information...

Publications

Immune profiling and identification of prognostic immune-related risk factors in human ovarian cancer
Rådestad E, Klynning C, Stikvoort A, Mogensen O, Nava S, Magalhaes I, et al
Oncoimmunology 2019;8(2):e1535730-

Individualization of Hematopoietic Stem Cell Transplantation Using Alpha/Beta T-Cell Depletion
Rådestad E, Sundin M, Törlén J, Thunberg S, Önfelt B, Ljungman P, et al
Frontiers in immunology 2019;10():189-

Methylseleninic Acid Sensitizes Ovarian Cancer Cells to T-Cell Mediated Killing by Decreasing PDL1 and VEGF Levels
Nair D, Rådestad E, Khalkar P, Diaz-argelich N, Schröder A, Klynning C, et al
Frontiers in oncology 2018;8():407-

Characterization of infiltrating lymphocytes in human benign and malignant prostate tissue
Rådestad E, Egevad L, Jorns C, Mattsson J, Sundberg B, Nava S, et al
Oncotarget 2017;8(36):60257-60269

Combining Flow and Mass Cytometry in the Search for Biomarkers in Chronic Graft-versus-Host Disease
Stikvoort A, Chen Y, Rådestad E, Törlén J, Lakshmikanth T, Björklund A, et al
Frontiers in immunology 2017;8():717-

Progression of benign prostatic hyperplasia is associated with pro-inflammatory mediators and chronic activation of prostate-infiltrating lymphocytes
Norström Mm, Rådestad E, Sundberg B, Mattsson J, Henningsohn L, Levitsky V, et al
Oncotarget 2016;7(17):23581-93

Alpha/beta T-cell depleted grafts as an immunological booster to treat graft failure after hematopoietic stem cell transplantation with HLA-matched related and unrelated donors
Rådestad E, Wikell H, Engström M, Watz E, Sundberg B, Thunberg S, et al
Journal of immunology research 2014;2014():578741-

Novel method to characterize immune cells from human prostate tissue
Norström Mm, Rådestad E, Stikvoort A, Egevad L, Bergqvist M, Henningsohn L, et al
The Prostate 2014;74(14):1391-9